title: Biopsy-driven diagnosis in infants with cholestatic jaundice in Iran.
abstract: OBJECTIVE
  To determine the frequencies of diagnoses confirmed by liver biopsy in infants with cholestasis in an Iranian pediatric hospital.
  
  
  METHODS
  This was a retrospective study conducted in a tertiary referral children's hospital in Iran. We retrieved all pathology reports of liver biopsies from children less than two years of age who had presented for evaluation of cholestatic jaundice from March 2001 to March 2011. Additional specimen samples obtained from archived pathology blocks were reviewed by a pathologist blinded to the final diagnosis. These results were compared with the pathology reports from chart records to ensure consensus and eliminate any inconsistencies in final diagnoses. A structured checklist was used to gather information on multiple variables including age, sex, gestational age at birth, birth weight, age at which hyperbilirubinemia manifested, presence and identification of associated anomalies, clinical manifestations, and histological findings from liver biopsies. The baseline data are reported using descriptive statistics, and differences between groups were assessed by Fisher's exact test and Student's t test when indicated.
  
  
  RESULTS
  Fifty-five cases (28 females; 27 males) of infantile cholestasis (IC) were included in this study. The mean serum total bilirubin and direct bilirubin at presentation were 13.6 ± 5.9 and 7.3 ± 3.4, respectively. Forty cases (72.7%) were the product of term pregnancies. Common associated clinical findings were acholic stool in 33 cases (60.0%), hepatomegaly in 30 cases (54.5%), and dark-colored urine in 21 cases (38.2%). Biliary atresia (BA) was the most frequent diagnosis, found in 32 cases (58.2%), followed by intrahepatic bile duct paucity found in 6 cases (10.9%), metabolic disease in 6 cases (10.9%), idiopathic neonatal hepatitis in 5 cases (9.1%), choledochal cyst in 2 cases (3.6%), liver cirrhosis in 2 cases (3.6%), and progressive familial intrahepatic cholestasis and portal fibrosis each in 1 case (1.8%). The mean times for jaundice onset and liver biopsy were 43.8 and 102.0 d, respectively. In BA, the mean age at jaundice presentation was 21 d and for liver biopsy was 87.5 d, representing a mean delay of 66.5 d.
  
  
  CONCLUSIONS
  A significant delay was found between IC presentation and liver biopsy, which is detrimental in conditions that can cause irreversible liver damage, such as BA.
authors.affiliation: Elham Talachian, Nahid Nick-khah, Department of Pediatric Gastroenterology, Ali Asghar Children's Hospital, Iran University of Medical Sciences, Tehran 1919816766, Iran.
authors.forename: Elham
authors.initials: E
authors.lastname: Talachian
authors.affiliation: Elham Talachian, Nahid Nick-khah, Department of Pediatric Gastroenterology, Ali Asghar Children's Hospital, Iran University of Medical Sciences, Tehran 1919816766, Iran.
authors.forename: Ali
authors.initials: A
authors.lastname: Bidari
authors.affiliation: Elham Talachian, Nahid Nick-khah, Department of Pediatric Gastroenterology, Ali Asghar Children's Hospital, Iran University of Medical Sciences, Tehran 1919816766, Iran.
authors.forename: Mitra
authors.initials: M
authors.lastname: Mehrazma
authors.affiliation: Elham Talachian, Nahid Nick-khah, Department of Pediatric Gastroenterology, Ali Asghar Children's Hospital, Iran University of Medical Sciences, Tehran 1919816766, Iran.
authors.forename: Nahid
authors.initials: N
authors.lastname: Nick-khah
mesh_terms: D000367:Age Factors; D001663:Bilirubin / Q000097:blood; D015415:Biomarkers / Q000097:blood; D001706:Biopsy; D002675:Child, Preschool; D042241:Early Diagnosis; D005260:Female; D006776:Hospitals, Pediatric; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007492:Iran; D007567:Jaundice, Neonatal / Q000097:blood / Q000209:etiology / Q000473:pathology*; D041781:Jaundice, Obstructive / Q000097:blood / Q000209:etiology / Q000473:pathology*; D008099:Liver / Q000473:pathology*; D008297:Male; D011237:Predictive Value of Tests; D011379:Prognosis; D012189:Retrospective Studies; D062606:Tertiary Care Centers; D013997:Time Factors
chemical_list: D015415:Biomarkers; D001663:Bilirubin
keywords: Biliary atresia; Cholestasis; Conjugated hyperbilirubinemia; Hepatitis; Infant; Liver biopsy; Neonatal hepatitis; Neonate